Jove
Visualize
Contact Us

Related Experiment Videos

Antigen presentation in allergic sensitization

G C Mudde1, I G Reischul, N Corvaïa

  • 1Department of Immunodermatology, Sandoz Research Institute, Vienna, Austria.

Immunology and Cell Biology
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.

Vaccine·2017
Same author

Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.

Protein engineering, design & selection : PEDS·2010
Same author

IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2009
Same author

Therapeutic antibodies and derivatives: from the bench to the clinic.

Current pharmaceutical biotechnology·2008
Same author

Development of novel protein scaffolds as alternatives to whole antibodies for imaging and therapy: status on discovery research and clinical validation.

Current pharmaceutical biotechnology·2008
Same author

Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.

Cancer gene therapy·2008
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Immunoglobulin E (IgE) antibodies trigger immediate allergic reactions and can worsen allergies by promoting immune cell activation. Controlling IgE production may prevent allergy progression and treat symptoms.

Area of Science:

  • Immunology
  • Allergy Pathogenesis

Background:

  • Immunoglobulin E (IgE) antibodies are central to immediate hypersensitivity reactions.
  • IgE also plays indirect roles in allergic disease pathogenesis, including antigen presentation.
  • This can lead to sustained immune activation and expansion of Th2 cells.

Purpose of the Study:

  • To explore the multifaceted roles of IgE in allergic diseases.
  • To investigate how IgE-mediated antigen presentation contributes to allergy progression.
  • To hypothesize the role of monocytes in regulating IgE responses.

Main Methods:

  • Review of IgE antibody functions in effector cells (mast cells, basophils).
  • Analysis of IgE's role in antigen-presenting cells and T-helper 2 (Th2) cell expansion.

Related Experiment Videos

  • Examination of CD23/IgE-mediated allergen presentation by B cells.
  • Consideration of monocyte Fc epsilon RI expression and function.
  • Main Results:

    • IgE cross-linking on effector cells causes immediate hypersensitivity.
    • IgE enhances antigen capture, leading to continuous immune activation and Th2 cell expansion.
    • This mechanism may explain the shift from single to multiple allergen sensitivities.
    • Monocytes expressing Fc epsilon RI might clear IgE and redirect immune responses.

    Conclusions:

    • Controlling IgE production is crucial for treating allergic symptoms.
    • Regulating IgE may prevent the deterioration of allergy to multiple allergens.
    • Monocyte involvement in IgE regulation warrants further investigation.